Clopidogrel News and Research

RSS
Clopidogrel is an oral antiplatelet agent (thienopyridine class) to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
Extended P2Y12 inhibitor monotherapy reduces bleeding and ischemic events in ACS patients

Extended P2Y12 inhibitor monotherapy reduces bleeding and ischemic events in ACS patients

Common genetic variants reduce clopidogrel effectiveness in British South Asians

Common genetic variants reduce clopidogrel effectiveness in British South Asians

Medications for chronic diseases can impair thermoregulation, especially in hot weather

Medications for chronic diseases can impair thermoregulation, especially in hot weather

Researchers discover a new switching point that regulates hemostasis and thrombosis

Researchers discover a new switching point that regulates hemostasis and thrombosis

Dual antiplatelet therapy for minor or a warning stroke is underused especially among women

Dual antiplatelet therapy for minor or a warning stroke is underused especially among women

What are the long-term outcomes of critical COVID-19 patients?

What are the long-term outcomes of critical COVID-19 patients?

Does nirmatrelvir and ritonavir reduce the risk of hospitalization or death among outpatients with early COVID-19?

Does nirmatrelvir and ritonavir reduce the risk of hospitalization or death among outpatients with early COVID-19?

Investigating plasma signatures of platelet-derived proteins in acute pulmonary embolism

Investigating plasma signatures of platelet-derived proteins in acute pulmonary embolism

What is currently known about the mechanism and treatments of long COVID?

What is currently known about the mechanism and treatments of long COVID?

Clopidogrel monotherapy linked with reduced risk of net adverse clinical events, study finds

Clopidogrel monotherapy linked with reduced risk of net adverse clinical events, study finds

Scientists identify innovative treatment approach for arterial thromboses

Scientists identify innovative treatment approach for arterial thromboses

Patients treated with edoxaban after TAVR do not find reduction in mini strokes, blood clots in the brain

Patients treated with edoxaban after TAVR do not find reduction in mini strokes, blood clots in the brain

AAN issues practice advisory for preventing second stroke in people with intracranial atherosclerosis

AAN issues practice advisory for preventing second stroke in people with intracranial atherosclerosis

Identifying and managing drug-drug interactions key to the safe use of nirmatrelvir–ritonavir in COVID-19 treatment

Identifying and managing drug-drug interactions key to the safe use of nirmatrelvir–ritonavir in COVID-19 treatment

Anti-platelet drug class fails to extend survival in moderately ill COVID-19 patients

Anti-platelet drug class fails to extend survival in moderately ill COVID-19 patients

Trial examines differences in gastrointestinal effects of antiplatelet therapy after PCI

Trial examines differences in gastrointestinal effects of antiplatelet therapy after PCI

Research reveals a new role for platelets in COVID-19 blood vessel damage

Research reveals a new role for platelets in COVID-19 blood vessel damage

Trial tests effectiveness of two prospective stroke therapies over standard of care

Trial tests effectiveness of two prospective stroke therapies over standard of care

ESO guidelines focus on early management of transient ischemic attack

ESO guidelines focus on early management of transient ischemic attack

Study highlights the role of genetic testing in evaluation of in-stent thrombosis

Study highlights the role of genetic testing in evaluation of in-stent thrombosis